SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001571049-17-006728
Filing Date
2017-07-17
Accepted
2017-07-17 08:57:16
Documents
8
Filing Date Changed
2017-07-17

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM S-1 t1702095-s1a.htm S-1/A 666886
2 EXHIBIT 1.1 t1702095_ex1-1.htm EX-1.1 237568
3 EXHIBIT 3.5 t1702095_ex3-5.htm EX-3.5 114615
4 EXHIBIT 4.3 t1702095_ex4-3.htm EX-4.3 115960
5 EXHIBIT 5.1 t1702095_ex5-1.htm EX-5.1 14000
6 EXHIBIT 23.1 t1702095_ex23-1.htm EX-23.1 2401
7 GRAPHIC lg_cyclacel-withregmark.jpg GRAPHIC 124046
8 GRAPHIC t1702095_ex5-1logo.jpg GRAPHIC 5393
  Complete submission text file 0001571049-17-006728.txt   1331115
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-218305 | Film No.: 17966720
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1